Expression of multixenobiotic resistance mechanism in a marine mussel Mytilus galloprovincialis as a biomarker of exposure to polluted environments

Comparative Biochemistry and Physiology - C Pharmacology Toxicology and Endocrinology

Volumn 113, Issue 2, 1996, Pages 283-289

  Kurelec, Branko ^a   Krca S ^a   Lucic D ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

biomarker; functional analysis; immunodetection; induction; multixenobiotic resistance; Mytilus galloprovincialis; P glycoprotein

Indexed keywords

BIOLOGICAL MARKER; ENVIRONMENTAL CHEMICAL; GLYCOPROTEIN P; RADIOISOTOPE; VERAPAMIL; VINCRISTINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG SENSITIVITY; GILL; IMMUNOBLOTTING; IMMUNOCHEMISTRY; INDIVIDUALITY; MARINE ENVIRONMENT; MEDITERRANEAN SEA; MEMBRANE VESICLE; MULTIDRUG RESISTANCE; MUSSEL; NONHUMAN; POLLUTION; PRIORITY JOURNAL; SEASON;

EID: 0029930094     PISSN: 07428413     EISSN: None     Source Type: Journal    
DOI: 10.1016/0742-8413(96)84525-7     Document Type: Conference Paper

References (35)

1. Burt, R.K.; Thorgeirsson, S.S. Coinduction of MDR-1 multidrug-resistance and cytochrome P-450 genes in rat liver by xenobiotics. J. Natl. Cancer Inst. 80:1383-1386;1988.
2. Center, M.S. Mechanisms regulating cell resistance to adriamycin: evidence that drug accumulation in resistant cells is modulated by phosphorylation of a plasma membrane glycoprotein. Biochem. Pharmacol. 34:1471-1476;1985.
3. Chambers, T.C.; Chalikonda, I.; Eilon, G. Correlation of protein kinase C translocation, P-glycoprotein phosphorylation and reduced drug accumulation in multidrug resistant human KB cells. Biophys. Res. Commun. Biochem. 169:253-259;1990.
4. Chan, K.M.; Davies, P.L.; Childs, S.; Veinot, S.; Ling, V. P-glycoprotein genes in the winter flounder, Pleuronectes americanus: isolation of two types of genomic clones carrying 3′ terminal exons. Acta Biochim. Biophys. 1171:65-72;1992.
5. Chieli, E.; Santonirugiu, E.; Cervelli, F.; Sabbatini, A.; Petrini, M.; Romiti, N.; Paolicchi, A.; Tongiani, R. Differential modulation of P-glycoprotein expression by dexamethasone and 3-methylcholantherne in rat hepatocyte primary cultures. Carcinogenesis 15:335-341;1994-
6. Cornwell, M.M.; Safe, A.R.; Felsted, R.L.; Gottesman, M.M.; Pastan, I.H. Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150-to 170-kDa protein detected by photoaffinity labeling. Proc. Natl. Acad. Sci. USA 83:3847-3852;1986.
7. Duensing, T.D.; Slate, D.L. Intracellular expression of P-glycoprotein in a human colon tumor cell line. Anticancer Res. 14:13-19;1994.
8. Endicott, J.A.; Ling, V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem. 58:137-171;1989.
9. Ford, J.M.; Hait, W.N. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 42:155-199;1990.
10. Gant, T.W.; Silverman, J.A.; Bisgaard, H.C.; Burt, R.K.; Marino, P.A.; Torgeirsson, S.S. Regulation of 2-acetylamonofluorene mediated and 3-methylcholanthrene mediated induction of multidrug resistance and cytochrome-P4501A gene family expression in primary hepatocyte cultures and rat liver. Mol. Carcinogen. 4:499-509;1991.
11. Gros, P.; Talbot, F.; Tang-Wai, D.; Bibi, E.; Kaback, H.R. Lipophilic cations: A group of model substrates for the multidrug-resistance. Biochemistry 31:1992-1998;1992.
12. Holland-Toomey, B.; Epel, D. Multixenobiotic resistance in Urechis embryos: Protection from environmental toxins. Biol. Bull. 185:355-364;1993.
13. Horio, M.; Gottesman, M.M.; Pastan, I. ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc. Natl. Acad. Sci. USA 85:3580-3584;1988.
14. Huet, S.; Schott, B.; Robert, J. P-glycoprotein overexpression cannot explain the complete doxorubicin-resistance phenotype in rat glioblastoma cell lynes. Br. J. Cancer. 65:538-544;1992.
15. Kioka, N.; Yamano, Y.; Komano, T.; Ueda, K. Heat shock responsive elements in the induction of the multidrug resistance gene (MDR1). FEBS Lett. 301:37-40;1992.
16. Kurelec, B. The multixenobiotic resistance mechanism in aquatic organisms. Crit. Rev. Toxicol. 22:23-43;1992.
17. Kurelec, B. Reversion of multixenobiotic resistance mechanism in gills of a marine mussel Mytilus galloprovincialis by model-and environmental-inhibitors of P170-glycoprotein. Aquatic Toxicol. 33:93-103;1995.
18. Kurelec, B. Inhibition of multixenobiotic resistance mechanism in aquatic organisms: Ecotoxic consequences. Sci. Total Environ. 171:197-204;1995.
19. Kurelec, B.; Britvic, S.; Rijavec, M.; Müller, W. E. G.; Zahn, R.K. Benzo(a)pyrene monooxygenase induction in marine fish - Molecular response to oil pollution. Mar. Biol. 44:211-216;1977.
20. Kurelec, B.; Lucić, D.; Pivčevic, B.; Krča, S. Induction and reversion of multixenobiotic resistance in a marine snail Monodonta turbinata. Mar. Biol. 123:305-312;1995.
21. Kurelec, B.; Pivčević, B. Evidence for a multixenobiotic resistance mechanism in the mussel Mytilus galloprovincialis. Aquat. Toxicol. 19:291-302;1991.
22. Kurelec, B.; Pivčević, B.; Müller, W.E.G. Determination of pollutants with multixenobiotic-resistance inhibiting properties. Mar. Envir. Res. 39:261-265;1995.
23. Ma, L.; Marquardt, D.; Takemoto, L.; Center, M.S. Analysis of P-glycoprotein phosphorylation in HL60 cells isolated for resistance to vincristine. J. Biol. Chem. 266:5593-5599;1991.
24. Minier, C.; Akcha, F.; Galgani, F. P-glycoprotein expression in Crossostrea gigas and Mytilus edulis in polluted seawater. Comp. Biochem. Physiol. 106B:1029-1036;1993.
25. Moore, M. Cellular and molecular biology and pathology. In: Report 1991-1992. Plymouth: Plymouth Marine Laboratory; 1992: 45-46.
26. Morrow, C. S.; Cowan, K. H. Mechanisms and clinical significance of multidrug resistance. Oncology 2:55-66;1988.
27. Moscow, J.A.; Fairchild, C.R.; Madden, M.J.; Ransom, D.T.; Wieand, H.S.; O'Brien, E.E.; Poplack, D.G.; Cossman, J.; Myers, C.E.; Cowan, K.H. Expression of antonic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res. 49:1422-1428;1989.
28. Muller, C.; Bailly, J.D.; Jaffrezou, J.P.; Goubin, F.; Laurent, G. Pharmacological control of P-glycoprotein expression. Bull. Cancer 81:386-391;1994.
29. Pierre, A.; Dunn, T.A.; Kruas-Bertier, L.; Leonce, S.; Saint-Dizier, D.; Regnier, G.; Dhainaut, A.; Berlion, M.; Bizzari, J.-P.; Atassi, G. In vitro and in vivo circumvention of multidrug resistance by Servier 9788, a novel triazinoaminopiperidine derivative. Invest. New Drugs 10:137-148;1992.
30. Roninson, I.B. The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo. Biochem. Pharmacol. 43:95-102;1992.
31. Shen, D.W.; Fojo, A.; Chin, J.E.; Roninson, I.B.; Richert, N.; Pastan, I.; Gottesman, M.M. Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. Science 232:643-645;1986.
32. Thorgeirsson, S.S.; Huber, B.E.; Sorrell, S.; Fojo, A.; Pastan, I.; Gottesman, M.M. Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver. Science 236: 1120-1121;1987.
33. Ueda, K.; Cornwell, M.M.; Gottesman, M.; Pastan, I.; Roninson, I.; Ling, V.; Riordan, J.R. The mdr1 gene, responsible for multidrug-resistance, codes for the p-glycoprotein. Biochem. Biophys. Res. Comm. 141:956-962;1986.
34. Waldmann, P.; Pivčević, B.; Mueller, W.E.G.; Zahn, R.K.; Kurelec, B. Increased genotoxicity of acetylaminofluorene by modulators of multixenobiotic resistance mechanism: Studies with the fresh water clam Corbicula fluminea. Mutat. Res. 342: 113-123;1995.
35. Yusa, K.; Tsuruo, T. Reversal mechanism of multidrug resistance by verapamil to P-glycoprotein on specific sites and transport of verapamil outwards across the plasma membrane of K562/ADM cells. Cancer Res. 49:5002-5006;1989.